
In early March, the New Jersey Superior Court upheld a separate jury verdict that found Merck adequately warned physicians of the risks associated with Vioxx. A week later, a New Jersey jury awarded a plaintiff $20 million and held that Vioxx caused the plaintiff's heart attack and, had the plaintiff's doctor known of the risks associated with Vioxx, he would not have prescribed it to the plaintiff. Merck faces more than 27,000 lawsuits from people who say they were harmed by the once $2.5 billion-a-year drug before it was pulled from the market [press release] in September 2004. Merck has set aside $1 billion to fight every Vioxx court challenge. In November 2006, a federal judge declined to certify a national class action suit, ruling that it made more sense to try the cases in their respective states of origin.